Trial Details

COMPLETED
Basic Information
Clinical ID c4511
Identifier NCT00401479
Trial Title A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome (IBS)
Interventions DRUG: Placebo|DRUG: Solabegron (GW427353)
Participant Information
Sponsor GlaxoSmithKline
City Rochester
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2006-10
Primary Completion Date -
Completion Date -